Resource Center
Tailoring CMV Prophylaxis Based On T Cell Immunity Panel Assessment in Kidney Transplant Patients at High Risk of CMV
Join us for an insightful on-demand webinar featuring Abigail Servais, PharmD, BCTXP, and Steve Kleiboeker, PhD, as they delve into a groundbreaking protocol at an academic medical center. This protocol incorporates serial assessment of CMV T Cell Immunity Panel (CMV-TCIP) to tailor valganciclovir prophylaxis duration for high-risk kidney transplant patients. Discover their findings on the risk of CMV disease following early discontinuation of prophylaxis and the predictors identified through CMV T cell immunity assessment.
Please fill out the form to access the resource.
Having trouble loading the form on mobile?
This form requires cookies to be enabled. If it doesn’t load, please check your browser’s cookie settings or open this page in a desktop browser.
This form requires cookies to be enabled. If it doesn’t load, please check your browser’s cookie settings or open this page in a desktop browser.
Search the Eurofins Viracor online test directory
for the most up-to-date assay offerings and information
Test Menu